Clinical trial
Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for…
NCT03039751 · Kuopio University Hospital, Other · Completed
Key facts
| NCT number | NCT03039751 |
|---|---|
| Title | Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris |
| Official title | Clinical Development and Proof of Principle Testing of New Regenerative Adenovirus Vascular Endothelial Growth Factor (VEGF-D) Therapy for Cost-effective Treatment of Refractory Angina. A Phase II Randomized, Double-blinded, Placebo-controlled Study (ReGenHeart) |
| Acronym | ReGenHeart |
| Lead sponsor | Kuopio University Hospital, Other |
| Collaborators | Queen Mary University of London University College, London Medical University of Vienna Servicio Madrileño de Salud, Madrid, Spain FinVector Vision Therapies Oy Śląski Uniwersytet Medyczny w… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | AdvVEGF-D, Control Rx |
| Enrollment | 63 |
| Start date | Oct 19, 2019 |
| Primary completion | Dec 31, 2023 |
| Completion | Dec 31, 2023 |
| First posted | Feb 1, 2017 |
| Last update posted | Jan 13, 2025 |
| Countries | Denmark, Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: